Cancer

HSCI scientist receives award for lung cancer research

November 13, 2020

HSCI Executive Committee member Carla Kim is a recipient of the Lung Cancer Discovery Award from the American Lung Association. The award recognizes Kim’s innovative lung cancer research that has the potential to improve patient care and help save lives.

“As our nation faces COVID-19, we have not only witnessed its toll on our health, but we have also seen how air pollution,...

Read more about HSCI scientist receives award for lung cancer research

HSCI scientist awarded grant to develop gene therapy for HIV

September 7, 2020

HSCI co-director David Scadden is part of a multi-institutional, cross-disciplinary team that has been awarded a $14.6 million grant from the National Institutes of Health. The team is using gene and cell therapy approaches to develop a potential cure for HIV.

The researchers will combine gene editing against HIV with technologies for safer and more effective blood stem cell transplants. Such transplants, also known as bone marrow transplants, are currently used for severe blood cancers. They renew a patient’s immune system, which can be damaged by cancer therapies, by...

Read more about HSCI scientist awarded grant to develop gene therapy for HIV

HSCI scientist recognized for outstanding dermatology research

May 26, 2020

HSCI scientist Ya-Chieh Hsu, Ph.D. is the recipient of the 2020 LEO Foundation Award. The award recognizes extraordinary contributions to dermatology research that advance our understanding of skin diseases, and have the potential to pave the way for new and improved treatments.

Hsu is the Alvin and Esta Star Associate Professor of Stem Cell and Regenerative Biology. She studies how communication among different cell...

Read more about HSCI scientist recognized for outstanding dermatology research

Pages